Zenlabs

Chandigarh, India Founded: 2008 • Age: 18 yrs
Pharmaceutical drugs for multiple therapeutic areas are manufactured by Zenlabs.
Annual revenue $8.1M Latest available
Total funding - Funding intelligence
Employees 16 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Zenlabs

Zenlabs is a company based in Chandigarh (India) founded in 2008. The company has 16 employees as of April 05, 2024. Zenlabs offers products and services including Analgesics and Anti-Inflammatory Drugs and Nutraceuticals.

  • Headquarter Chandigarh, India
  • Employees 16 as on 05 Apr, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zenlabs Ethica Ltd
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Nutrition, Wellness & Lifestyle Health
Key Metrics
  • Annual Revenue
    $8.06 M (USD)
    -3.12
    as on Mar 31, 2023
  • Net Profit
    $58.83 K (USD)
    -40.51
    as on Mar 31, 2023
  • EBITDA
    $349.06 K (USD)
    19.17
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    16

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Zenlabs

Zenlabs is a publicly listed company on the BSE with ticker symbol ZENLABS in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: BSE · Ticker: ZENLABS · Sector: Health technology · India

Products & Services of Zenlabs

Zenlabs offers a comprehensive portfolio of products and services, including Analgesics and Anti-Inflammatory Drugs and Nutraceuticals.

Primary

These drugs are manufactured for the treatment of pain and inflammation.

Nutraceuticals are provided to support nutritional needs and overall health.

Funding Insights of Zenlabs

Investments & Acquisitions by Zenlabs

Investments

Financial Statements - Zenlabs

Zenlabs Comparisons

+
Add Comparison
Available on Premium

Competitors of Zenlabs

Latest news on Zenlabs

Frequently Asked Questions about Zenlabs

Zenlabs was founded in 2008.

Zenlabs is headquartered in Chandigarh, India.

Sanjeev Kumar is the current CEO of Zenlabs.

As of Apr 05, 2024, the latest employee count at Zenlabs is 16.

Annual revenue of Zenlabs is $8.06M as on Mar 31, 2023.

Zenlabs was established in 2008 in Chandigarh, India, within the pharmaceutical sector. Focus is placed on the production of drugs targeting various therapeutic areas. Operations are conducted from the companys base in India, serving needs in healthcare through manufacturing processes. Leadership is provided by Managing Director and CEO Sanjeev Kumar, with regulatory details including DIN 01154896 and PAN ACSPK6038N noted for compliance. The domain zenlabsethica.com supports online presence.

Zenlabs offers Analgesics and Anti-Inflammatory Drugs and Nutraceuticals.

Yes, Zenlabs is publicly traded on BSE under the ticker symbol ZENLABS.

The ticker symbol of Zenlabs is ZENLABS on BSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available